Medical devices company Terumo India inks pact with Argon Medical to expand portfolio
Advertisement
New Delhi: Terumo India, the Indian arm of Terumo Corporation, today announced that it has signed a partnership agreement with Argon Medical. Terumo and Argon have complementary portfolios, enabling Terumo to offer advanced medical solutions, providing support from diagnosis to treatment across the patient-care pathway.
Making the announcement, Shishir Agarwal, MD of Terumo India, said, "Bridging the industry gap in providing patient focused solutions for healthcare providers is a priority for Terumo. We are delighted to introduce Argon products in India, which represent the gold standard for Biopsy Devices and complements our portfolio of Vascular Solutions, Access and Core Products."
Commenting on the development, Argon Medical's President and CEO, George Leondis said, "At Argon Medical, we take pride in our mission to improve the lives of patients and caregivers through innovation, manufacturing and delivery of best-in-class devices. We are excited to work together with Terumo India in this new long-term partnership, to make our products available in India and improve patient care."
Cancer is one of the most prevalent chronic diseases in India today. With over 1.4 M cancer patients being diagnosed annually, the need for biopsies has multiplied significantly. Other diseases such as Chronic Kidney Disease, have over 16% prevalence within the Indian population. There is a significant unmet need to provide the latest technologies and tools for procedures such as Biopsies, AV Access and Deep Vein Thrombosis treatments. Argon's portfolio comprising Biopsy, Thrombectomy and IVC Filters and Retrieval kits is expected to help bridge this gap for the Indian market.
Founded in 2013, Terumo India is a medical devices company headquartered in Gurgaon, NCR Delhi. Terumo India is part of Terumo Corporation, a global leader in medical technology with headquarters in Tokyo, Japan and over 25,000 associates worldwide.
Read also: Gabri Labs to construct Rs 37 crore medical devices facility in Dubai
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.